HALEON PLC at UBS European Conference (Virtual) Transcript
Hello, everyone, and welcome to this fireside chat. My name is Guillaume Delmas, I have the European food and HPC team here at UBS. So today, we are absolutely delighted to have with us Tobias Hestler, GSK Consumer Healthcare, Chief Financial Officer.
Tobias, thank you very much for taking the time today to answer our questions. Now, we've got half an hour. So for the purpose of today's fireside chat, I was thinking about starting with a focus on GSK Consumer Healthcare organic sales growth prospects before turning my attention to your margin opportunities.
And with that, let's begin.
Questions & Answers
So on organic sales growth, you anticipate medium-term category growth of 3% to 4% in oral care, 4% to 5% in VMS, 2% to 3% in OTC; which gives broadly a sales weighted average of around 3%. Now you've clearly stated that your ambition is to grow ahead of the market. So maybe can we start by you shedding some light of the main factors that should drive
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
